Yaping Zhao
Xi'an, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Deciphering the rules of disulfidptosis: a genome-wide signature for identifying disulfidptosis-related genes and analyzing hepatocellular carcinoma chemotherapy sensitivities.
Journal: Free radical biology & medicine
Published: July 24, 2025
Pharmacological Targeting of NRF2 Represents a Promising Therapeutic Approach for Pyroptosis-Related Non-Alcoholic Fatty Liver Disease.
Journal: Current medicinal chemistry
Published: June 04, 2025
Icaritin Attenuates HSC Activation by Down-regulating the HIF-1α and TGF-β/Smad Signaling Pathways to Ameliorate Liver Fibrosis.
Journal: Current medicinal chemistry
Published: November 01, 2024
Gaudichaudione H Enhances the Sensitivity of Hepatocellular Carcinoma Cells to Disulfidptosis via Regulating NRF2-SLC7A11 Signaling Pathway.
Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)
Published: September 11, 2024
Gaudichaudione H ameliorates liver fibrosis and inflammation by targeting NRF2 signaling pathway.
Journal: Free radical biology & medicine
Published: July 13, 2024
Protocatechuic acid relieves ferroptosis in hepatic lipotoxicity and steatosis via regulating NRF2 signaling pathway.
Journal: Cell biology and toxicology
Published: June 26, 2024
Liquiritigenin Confers Liver Protection by Enhancing NRF2 Signaling through Both Canonical and Non-canonical Signaling Pathways.
Journal: Journal of medicinal chemistry
Published: August 03, 2023
COX7A1 enhances the sensitivity of human NSCLC cells to cystine deprivation-induced ferroptosis via regulating mitochondrial metabolism.
Journal: Cell death & disease
Published: August 30, 2022
Diverse Role of SNARE Protein GS28 in Vesicle Trafficking and Diseases.
Journal: Current protein & peptide science
Published: May 16, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026